Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer
Nikhil Wagle(Dana-Farber Cancer Institute), Jochen H. Lorch(Northwestern University), David M. Sabatini(Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry), Daniel T. Ruan(Beth Israel Deaconess Medical Center), Nathanael S. Gray(Stanford University), Scott L. Carter(Broad Institute), Glenn J. Hanna(Dana-Farber Cancer Institute), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Pasi A. Jänne(Harvard University), Mara Rosenberg(Broad Institute), Levi A. Garraway(Broad Institute), Brian C. Grabiner(Howard Hughes Medical Institute), Ali Amin‐Mansour, Justine A. Barletta(Brigham and Women's Hospital), Amaro Taylor‐Weiner(Critical Path Institute), Robert I. Haddad(Georgetown University), Gad Getz(Broad Institute), David J. Kwiatkowski(Brigham and Women's Hospital), Steven Swanson(Brigham and Women's Hospital)
Cited by 327
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k